ACET
Price
$0.91
Change
-$0.06 (-6.25%)
Updated
Dec 18, 04:05 PM (EDT)
84 days until earnings call
KMDA
Price
$5.78
Change
+$0.03 (+0.52%)
Updated
Dec 18, 04:08 PM (EDT)
56 days until earnings call
Ad is loading...

ACET vs KMDA

Header iconACET vs KMDA Comparison
Open Charts ACET vs KMDABanner chart's image
Adicet Bio
Price$0.91
Change-$0.06 (-6.25%)
Volume$600
CapitalizationN/A
Kamada
Price$5.78
Change+$0.03 (+0.52%)
Volume$132
CapitalizationN/A
ACET vs KMDA Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. KMDA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and KMDA is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ACET: $0.96 vs. KMDA: $5.75)
Brand notoriety: ACET and KMDA are both not notable
ACET represents the Biotechnology, while KMDA is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 80% vs. KMDA: 58%
Market capitalization -- ACET: $78.73M vs. KMDA: $306.49M
ACET [@Biotechnology] is valued at $78.73M. KMDA’s [@Pharmaceuticals: Other] market capitalization is $306.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileKMDA’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • KMDA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish while KMDA’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 5 bullish, 3 bearish.
  • KMDA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than KMDA.

Price Growth

ACET (@Biotechnology) experienced а -9.87% price change this week, while KMDA (@Pharmaceuticals: Other) price change was -5.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.61%. For the same industry, the average monthly price growth was +1.68%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

ACET is expected to report earnings on Mar 12, 2025.

KMDA is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+0.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than ACET($78.7M). KMDA YTD gains are higher at: -6.046 vs. ACET (-49.450). KMDA has higher annual earnings (EBITDA): 22.4M vs. ACET (-111.35M). ACET has more cash in the bank: 202M vs. KMDA (55.6M). KMDA has less debt than ACET: KMDA (8.82M) vs ACET (18.2M). KMDA has higher revenues than ACET: KMDA (143M) vs ACET (0).
ACETKMDAACET / KMDA
Capitalization78.7M306M26%
EBITDA-111.35M22.4M-497%
Gain YTD-49.450-6.046818%
P/E RatioN/A37.43-
Revenue0143M-
Total Cash202M55.6M363%
Total Debt18.2M8.82M206%
FUNDAMENTALS RATINGS
ACET vs KMDA: Fundamental Ratings
ACET
KMDA
OUTLOOK RATING
1..100
5974
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9779
PRICE GROWTH RATING
1..100
6550
P/E GROWTH RATING
1..100
2396
SEASONALITY SCORE
1..100
2643

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (32) in the Medical Distributors industry is somewhat better than the same rating for KMDA (67) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than KMDA’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as KMDA (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's SMR Rating (79) in the Biotechnology industry is in the same range as ACET (97) in the Medical Distributors industry. This means that KMDA’s stock grew similarly to ACET’s over the last 12 months.

KMDA's Price Growth Rating (50) in the Biotechnology industry is in the same range as ACET (65) in the Medical Distributors industry. This means that KMDA’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (23) in the Medical Distributors industry is significantly better than the same rating for KMDA (96) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETKMDA
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 10 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
53%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSBIX13.21N/A
N/A
State Street Balanced Index K
PGFIX82.46N/A
N/A
Virtus Silvant Focused Growth Inst
BILSX9.60-0.02
-0.21%
BlackRock U.S. Insights Lon/Shr Eq Ins
CLSYX19.89-0.12
-0.60%
Columbia International Div Inc Inst3
BTEKX76.45-0.57
-0.74%
BlackRock Technology Opportunities K

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-0.75%
OGI - ACET
41%
Loosely correlated
+5.23%
KYMR - ACET
39%
Loosely correlated
-1.76%
DVAX - ACET
39%
Loosely correlated
+0.39%
CRON - ACET
36%
Loosely correlated
+1.04%
PRTA - ACET
36%
Loosely correlated
+11.34%
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and NXSCF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and NXSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.86%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
-0.43%
INCR - KMDA
27%
Poorly correlated
N/A
ACET - KMDA
22%
Poorly correlated
-0.75%
RDY - KMDA
22%
Poorly correlated
-1.43%
More